Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens

被引:23
作者
Berger, AP
Volgger, H
Rogatsch, H
Strohmeyer, D
Steiner, H
Klocker, H
Bartsch, G
Horninger, W
机构
[1] Univ Innsbruck, Dept Urol, A-6020 Innsbruck, Austria
[2] Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria
关键词
prostate cancer; PSA screening; positive margins;
D O I
10.1002/pros.10167
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. In the literature, positive margins in radical prostatectomy specimens, the rate of which ranges between 7% and 46%, are associated with adverse patient survival. The aim of the present study was to determine the predictive value of preoperative serum prostate specific antigen (PSA) values for the rate of positive margins in radical retropubic prostatectomy. METHODS. The study included a cohort of 845 patients who underwent radical retropubic prostatectomy between October of 1993 and December of 1999. All patients were stratified in groups on the basis of their preoperative PSA values: PSA group I, 0-1.99 ng/ml; PSA group II, 2-3.99 ng/ml; PSA group III, 4-5.99 ng/ml; PSA group IV, 6-7.99 ng/ml; PSA group V, 8-9.99 ng/ml; and PSA group VI, >10 ng/ml. For each group, the pathologic stage, Gleason score, and the incidence of positive margins were analyzed. For statistical analysis, the Mann Whitney U-test was used. RESULTS. Our data show a significantly higher rate of organ-confined prostate cancers and a significantly lower rate of positive surgical margins in patients with preoperative total PSA values of less than 4 ng/ml compared with patients with higher preoperative total PSA levels. CONCLUSION. As tumor stage and surgical margin status after radical prostatectomy are important predictors of the likelihood of PSA recurrence, which necessitates additional therapy, these findings support the concept of PSA screening by using low PSA cutoff levels.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 30 条
[1]   ANALYSIS OF RISK-FACTORS ASSOCIATED WITH PROSTATE-CANCER EXTENSION TO THE SURGICAL MARGIN AND PELVIC NODE METASTASIS AT RADICAL PROSTATECTOMY [J].
ACKERMAN, DA ;
BARRY, JM ;
WICKLUND, RA ;
OLSON, N ;
LOWE, BA .
JOURNAL OF UROLOGY, 1993, 150 (06) :1845-1850
[2]  
[Anonymous], 1997, AJCC CANC STAGING MA
[3]   Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy [J].
Blute, ML ;
Bergstralh, EJ ;
Iocca, A ;
Scherer, B ;
Zincke, H .
JOURNAL OF UROLOGY, 2001, 165 (01) :119-125
[4]   Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].
Catalona, WJ ;
Smith, DS ;
Ornstein, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455
[5]  
Cheng L, 1999, CANCER, V86, P1775, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1775::AID-CNCR20>3.0.CO
[6]  
2-L
[7]   The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Fondurulia, J ;
Chen, MH ;
Tomaszewski, JE ;
Wein, A .
JOURNAL OF UROLOGY, 1998, 160 (06) :2096-2101
[8]  
EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO
[9]  
2-Y
[10]   Incidence and significance of positive margins in radical prostatectomy specimens [J].
Epstein, JI .
UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) :651-&